AI assistant
EPWIN GROUP PLC — Regulatory Filings 2021
Jun 7, 2021
7627_dva_2021-06-07_3fb43167-046d-4775-aec3-89ed9402d647.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 0631B
Epwin Group PLC
07 June 2021
7 June 2021
Epwin Group Plc
Total Voting Rights
Epwin Group Plc (AIM: EPWN) ("Epwin" or the "Company"), the leading manufacturer of low maintenance building products, supplying the Repair, Maintenance and Improvement ("RMI"), new build and social housing sectors, confirms that as at 31 May 2021, the Company's issued ordinary share capital consisted of 145,297,556 ordinary shares of 0.05p each in the capital of the Company ("Ordinary Shares"), of which a total of 388,000 Ordinary Shares were held in treasury. Therefore, the total voting rights in the Company was 144,909,556. This figure should be used by shareholders as the denominator for the calculation by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contact information
| Epwin Group Plc Jon Bednall, Chief Executive Chris Empson, Group Finance Director |
0203 128 8168 | |
| Shore Capital (Nominated Adviser and Joint Broker) Corporate Advisory Edward Mansfield / Daniel Bush Corporate Broking Fiona Conroy Zeus Capital Limited (Joint Broker) John Goold / Dominic King |
0207 408 4090 0203 829 5000 |
|
| MHP Communications Reg Hoare / Charlie Barker / Florence Mayo / Pandora Yadgaroff |
0203 128 8168 [email protected] |
|
About Epwin
Epwin is the leading manufacturer of low maintenance building products, supplying the Repair, Maintenance and Improvement (" RMI"), new build and social housing sectors. The Company is incorporated, domiciled and operates principally in the United Kingdom.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRFLFVFRTIDIIL